Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

25 Jan 2018 15:35

RNS Number : 9693C
Cenkos Securities PLC
25 January 2018
 

25 January 2018

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Transaction in Own Shares

 

The Company announces that, in accordance with existing authority granted at the Company's annual general meeting in May 2017 enabling the Company to purchase its own ordinary shares of 1p each in the Company ("Ordinary Shares") should the Directors consider there to be a likely beneficial impact on the earning per Ordinary Shares and that it is in the best interests of the Company, the Company has today completed the on market purchase of 1,384,748 Ordinary Shares at an average price of 107.0 pence per Ordinary Share.

 

The Ordinary Shares repurchased by the Company will be held in treasury.

 

Following the purchase of these Ordinary Shares, the Company will have 55,310,035 Ordinary Shares in issue (excluding treasury shares) and will hold 1,384,748 Ordinary shares held in treasury.

 

The figure of 55,310,035 Ordinary Shares may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The Company will consider making further on market repurchases of Ordinary Shares within the authority in place in the future.

 

Enquiries:

 

Anthony Hotson +44 20 7397 8900

Chief Executive Officer

Cenkos Securities plc

 

Dr Azhic Basirov / David Jones / Ben Jeynes +44 20 7131 4000

Nominated Adviser

Smith & Williamson Corporate Finance Limited

 

David Rydell +44 20 3466 5066

Buchanan Communications

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSFKPDNPBKDQDB
Date   Source Headline
2nd Feb 202310:58 amRNSForm 8.5 (EPT/NON-RI)
31st Jan 20239:09 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20239:22 amRNSForm 8.5 (EPT/NON-RI)
26th Jan 202310:16 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
25th Jan 20239:22 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20239:20 amRNSForm 8.5 (EPT/NON-RI)
24th Jan 20238:55 amRNSForm 8.5 (EPT/NON-RI)
20th Jan 20239:05 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20238:26 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20238:41 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20238:37 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20238:45 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 20238:40 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20239:03 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20239:03 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20239:08 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20238:46 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20239:38 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20239:11 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20239:11 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20238:40 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20238:36 amRNSForm 8.5 (EPT/NON-RI)
6th Jan 20238:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 20238:17 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20239:20 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20239:14 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
30th Dec 20229:05 amRNSForm 8.5 (EPT/NON-RI)
29th Dec 20228:44 amRNSForm 8.5 (EPT/NON-RI)
29th Dec 20228:39 amRNSForm 8.5 (EPT/NON-RI)
22nd Dec 20228:56 amRNSForm 8.5 (EPT/NON-RI)
21st Dec 20229:22 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 202211:10 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 202210:23 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 20228:58 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 202210:26 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 202210:23 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 20229:45 amRNSForm 8.5 (EPT/NON-RI)
9th Dec 20228:46 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20228:36 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20228:34 amRNSForm 8.5 (EPT/NON-RI)
7th Dec 20221:34 pmEQSCenkos Securities sees combination of factors behind M&A slowdown
7th Dec 202210:46 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20228:54 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20228:51 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 202211:47 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
5th Dec 20227:00 amRNSDirectorate Change
2nd Dec 202210:09 amRNSForm 8.5 (EPT/NON-RI)
2nd Dec 202210:02 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 202210:00 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 20229:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.